Fadi Haddad, Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center shared on X:
“New US FDA approval of BLINCYTO as consolidation for patients with acute lymphoblastic leukemia.
If you are a patient or caregiver click on the link to learn everything about this new approval.”
Source: Fadi Haddad/X